Clinical Trials for Cancer Treatment

Cancer Type	Principal Investigator	Keyword OR ClinicalTrials.Gov ID
Please selectAcute Leukemia Bladder/Urinary Tract (TCC) Blood Disorders Brain/Central Nervous System Breast Chronic Leukemia Colon Gynecologic Head & Neck Hodgkin Disease Immunotherapy Kidney/Wilms Tumor Liver Lung Multiple Myeloma Myelodysplastic Syndrome Neuroblastoma Non-Hodgkin Lymphoma Other Pancreatic/Neuroendocrine Pediatric Prostate Radiation Rectal/Anal Registry Sarcoma Symptom Management Testicular Transplant	-Any-Paul D Aridgides Alexander Banashkevich, MD Alina Basnet Sam Benjamin, MD Jeffrey A Bogart, MD Gennady Bratslavsky, MD Melanie A Comito Mary J Cunningham, MD Teresa C Gentile, MD, PhD Krishna B Ghimire, MD Stephen L Graziano, MD Seung Shin Hahn, MD Joseph M Jacob, MD Michael D Mix, MD Philip Monteleone Dorothy C Pan, MD Bernard J Poiesz, MD Jeffrey J Pu Kathryn E Scott Rahul Seth, DO Anna Shapiro, MD Brittany A Simone Leonard B Weiner

You searched for Category (Breast): 10 trials found.

Click in the column header to sort records.

Study Title	PI
A011801 - THE COMPASSHER2 TRIALS (COMPREHENSIVE USE OF PATHOLOGIC RESPONSE ASSESSMENT TO OPTIMIZE THERAPY IN HER2-POSITIVE BREAST CANCER): COMPASSHER2 RESIDUAL DISEASE (RD), A DOUBLE-BLINDED, PHASE III RANDOMIZED TRIAL OF T-DM1 AND PLACEBO COMPARED WITH T-DM1 AND TUCATINIB Read more	Sam Benjamin, MD
AFT-65: ASCENT-05: A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy Read more	Sam Benjamin, MD
AN INTERVENTIONAL, OPEN-LABEL, RANDOMIZED, MULTICENTER PHASE 3 STUDY OF PF-07220060 PLUS FULVESTRANT COMPARED TO INVESTIGATOR’S CHOICE OF THERAPY IN PARTICIPANTS OVER 18 YEARS OF AGE WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE ADVANCED/METASTATIC REAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR CDK 4/6 INHIBITOR BASED THERAPY. Read more	Sam Benjamin, MD
CCTG MA.39 - TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer Read more	Anna Shapiro, MD
Intra-Operative Radiation Therapy (IORT) Registry and Quality of Life Survey in Early Stage Breast Cancer Read more	Anna Shapiro, MD
MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX) Read more	Sam Benjamin, MD
Neurocognitive changes in breast cancer patients on hormonal therapy. Is there a difference between objective and perceived neurocognition? Read more	Sam Benjamin, MD
NRG-BR007: A Phase III Clinical Trial Evaluating De-escalation Of Breast Radiation For Conservative Treatment Of Stage I, Hormone Sensitive, Her2-Negative, Oncotype Recurrence Score < 18 Breast Cancer Read more	Anna Shapiro, MD
NRG-BR008: A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer (HERO) Read more	Anna Shapiro, MD
Phase III Trial of Neoadjuvant Durvalumab (NSC 778709) plus Chemotherapy versus Chemotherapy Alone for Adults with MammaPrint Ultrahigh (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer Read more	Sam Benjamin, MD

Search Again